Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reyoung Beaute is the medical aesthetics and skincare division of Shandong Reyoung Pharmaceutical, a prominent Chinese pharmaceutical enterprise established in 1966. The company specializes in the research, development, and large-scale manufacturing of hyaluronic acid-based products, most notably its Reyoungel line of cross-linked dermal fillers. Their portfolio is designed to address various aesthetic concerns, including wrinkle reduction, facial contouring, and skin rejuvenation, as well as therapeutic applications like orthopedic injections. By leveraging the parent company's extensive GMP-certified manufacturing infrastructure, Reyoung Beaute provides high-quality medical aesthetic solutions to both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reyoung Beaute.